Office of Biotechnology Activities, Office of the Director; Notice of Meeting, 30474-30475 [05-10533]

Download as PDF 30474 Federal Register / Vol. 70, No. 101 / Thursday, May 26, 2005 / Notices 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301–496–8683. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: May 18, 2009. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10532 Filed 5–25–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Library of Medicine; Notice of Meeting Office of Biotechnology Activities, Office of the Director; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the sixth meeting of the Commission on Systemic Interoperability. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The mission of the Commission on Systemic Interoperability is to submit a report to the Secretary of Health and Human Services and to Congress on a comprehensive strategy for the adoption and implementation of health care information technology standards that includes a timeline and prioritization for such adoption and implementation. In developing that strategy, the Commission will consider: (1) The costs and benefits of the standards, both financial impact and quality improvement; (2) The current demand on industry resources to implement the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and other electronic standards, including HIPAA standards; and (3) The most cost-effective and efficient means for industry to implement the standards. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel, NIBIB Training Review. Date: June 29–30, 2005. Time: June 29, 2005, 6 p.m. to 9 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Time: June 30, 2005, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jabreel Boyd, Office of Scientific Review, National Institute of Biomedical Imaging and Bioengineering, Suite 920, Bethesda, MD 20892, 301–496– 8633, boydjab@od.nih.gov. Name of Committee: Commission on Systemic Interoperability. Date: June 14, 2005. Time: 8 a.m. to 4 p.m. Agenda: Healthcare Information Technology Standards. Place: Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, Washington, DC 20201. Contact Person: Ms. Dana Haza, Director, Commission on Systemic Interoperability, National Library of Medicine, National Institutes of Health, Building 38, Room 2N21, Bethesda, MD 20894. 301–594–7520. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: May 18, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10534 Filed 5–25–05; 8:45 am] Dated: May 19, 2005. Anna Snouffer, Deputy Director, Officer of Federal Advisory Committee Policy. [FR Doc. 05–10517 Filed 5–25–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M VerDate jul<14>2003 19:11 May 25, 2005 Jkt 205001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the inaugural meeting of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of usual-use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security. The meeting will be open to the public as indicated below. Preregistration is recommended due to space limitations. Persons planning to attend should register online at https:// www.biosecurityboard.gov/meeting.asp or by calling The Hill Group (Heather Thompson) at 301–897–2789, ext. 132. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration. Name of Committee: National Science Advisory Board for Biosecurity. Date: June 30–July 1, 2005. Open: 8 a.m. to 3 p.m. Agenda: (1) Presentation and discussions on criteria for defining dual-use research in the life sciences and the role of a code of conduct for the life sciences; (2) discuss issues raised by dual-use research with respect to scientific communication, genome synthesis, and international perspectives; (3) public comments; (4) and other business of the committee. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, Maryland. Contact Person: Thomas Holohan, M.D., NSABB Executive Director, 6705 Rockledge Drive, Bethesda, Maryland 20892. (301) 496– 9838. This meeting will also be webcast. The draft meeting agenda and other information about NSABB, including information about access to the webcast and pre-registration, will be available at https:// www.biosecurityboard.gov. Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization E:\FR\FM\26MYN1.SGM 26MYN1 Federal Register / Vol. 70, No. 101 / Thursday, May 26, 2005 / Notices represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments if accepted by the committee. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by June 17, 2005 and should be sent via e-mail to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Dr. Ansalan Stewart. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: May 18, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10533 Filed 5–25–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; National Center for Biomedical Computing. Date: May 25–27, 2005. Time: 7:30 pm. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health; National Library of Medicine Building, Lister Hill Auditorium, Bethesda, MD 20892. Contact Person: Sally Ann Amero, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4190, MSC 7849, Bethesda, MD 20892. 301–435– 1159. ameros@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. VerDate jul<14>2003 19:11 May 25, 2005 Jkt 205001 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 17, 2005. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10519 Filed 5–25–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Cellular Signaling and Dynamics, June 9, 2005, 8 a.m. to June 10, 2005, 5 p.m. Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD, 20815 which was published in the Federal Register on May 11, 2005, 70 FR 24829–24832. The meeting will be held at the Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. The meeting dates and time remain the same. The meeting is closed to the public. Dated: May 17, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–10520 Filed 5–25–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 30475 Name of Committee: Respiratory Sciences Integrated Review Group; Lung Cellular, Molecular, and Immunobiology Study Section. Date: June 15–16, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham City Center Hotel, 1143 New Hampshire Ave., NW., Washington, DC 20037. Contact Person: George M Barnas, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892. 301–435– 0696. barnasg@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Candida. Date: June 16, 2005. Time: 11 a.m. to 12:10 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Fouad A. El-Zaatari, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, MSC 7808, Bethesda, MD 20814–9692. 301– 435–1149. elzaataf@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Emphasis Panel for Pulmonary/Lung /Disorders. Date: June 16, 2005. Time: 4:30 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Karin F. Helmers, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD 20892. (301) 435– 1017. helmersk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 05–001: Strengthening Behavioral and Social Science in Medical Schools. Date: June 20–21, 2005. Time: 8:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lynn T. Nielsen-Bohlman, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3089F, MSC 7848, Bethesda, MD 20892. (301) 594– 5287. nielsenl@csr.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Arthritis, Connective Tissue and Skin Study Section. Date: June 20–21, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 70, Number 101 (Thursday, May 26, 2005)]
[Notices]
[Pages 30474-30475]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10533]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of the Director; 
Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the inaugural 
meeting of the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of usual-use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public as indicated below. Pre-
registration is recommended due to space limitations. Persons planning 
to attend should register online at https://www.biosecurityboard.gov/
meeting.asp or by calling The Hill Group (Heather Thompson) at 301-897-
2789, ext. 132. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should indicate these requirements upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: June 30-July 1, 2005.
    Open: 8 a.m. to 3 p.m.
    Agenda: (1) Presentation and discussions on criteria for 
defining dual-use research in the life sciences and the role of a 
code of conduct for the life sciences; (2) discuss issues raised by 
dual-use research with respect to scientific communication, genome 
synthesis, and international perspectives; (3) public comments; (4) 
and other business of the committee.
    Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, 
Maryland.
    Contact Person: Thomas Holohan, M.D., NSABB Executive Director, 
6705 Rockledge Drive, Bethesda, Maryland 20892. (301) 496-9838.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the webcast and pre-registration, will be available at https://
www.biosecurityboard.gov.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization

[[Page 30475]]

represented and a short description of the oral presentation. Only 
one representative of an organization may be allowed to present oral 
comments if accepted by the committee. Both printed and electronic 
copies are requested for the record. In addition, any interested 
person may file written comments with the committee. All written 
comments must be received by June 17, 2005 and should be sent via e-
mail to nsabb@od.nih.gov with ``NSABB Public Comment'' as the 
subject line or by regular mail to 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, Attention Dr. Ansalan Stewart. The statement 
should include the name, address, telephone number and, when 
applicable, the business or professional affiliation of the 
interested person.

    Dated: May 18, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10533 Filed 5-25-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.